Primaquine treatment for P. ovale infection in migrants with G6PD deficiency

J Travel Med. 2024 Dec 11:taae150. doi: 10.1093/jtm/taae150. Online ahead of print.

Carles Rubio Maturana^{1

2}, Patricia Martínez-Vallejo^{1

2}, Fernando Salvador^{3

4}, David Beneitez-Pastor⁵, Francesc Zarzuela Serrat¹, Elena Sulleiro^{1

2

4}, Diana Pou^{3

4}, Maria Luisa Aznar^{3

4}, Israel Molina^{3

4}, Núria Serre-Delcor^{3

4}, Inés Oliveira-Souto^{3

4}

¹ Microbiology Department. Vall d'Hebron University Hospital. Barcelona. Department of Genertics and Microbiology, Universitat Autònoma de Barcelona.
² Vall d'Hebron Research Institute (VHIR), Barcelona.
³ International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department. Vall d'Hebron University Hospital. PROSICS Barcelona. Barcelona. Universitat Autònoma de Barcelona.
⁴ Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
⁵ Hematology Department. CSUR Eritropatología Hereditaria. ERN-EuroBloodNet. Vall d'Hebron University Hospital. Barcelona. Universitat Autònoma de Barcelona.

No abstract available

Keywords: P. ovale, malaria; Glucose-6-phosphate dehydrogenase deficiency; Primaquine; sub-saharan africa.